 |
市场调查报告书
商品编码
1392099
全球恐慌发作治疗市场：依药物类别、途径、配销通路及地区划分Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography |
||||||
全球恐慌症治疗市场预计将从 2023 年的 21.4 亿美元增至 2030 年的 63.4 亿美元，预测期内复合年增长率为 16.8%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 21.4亿美元 |
| 实绩资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期复合年增长率 | 16.80% | 2030年市场规模预测 | 63.4亿美元 |
恐慌发作是突然而强烈的恐惧或痛苦的发作，可能会使经历这些症状的人变得虚弱。这些发作通常在毫无征兆的情况下发生，并可能导致心悸、气短和胸痛等身体症状。恐慌发作的治疗重点是缓解症状、减少发作频率和提高整体生活品质。
市场动态：
全球恐慌症治疗市场预计在不久的将来将出现显着成长。全球市场的成长是由多种因素推动的，其中包括全球恐慌发作的日益普及。人们对心理健康的认识不断提高，对恐慌发作的接受度和理解不断增强，也促进了市场的成长。医疗技术和治疗性介入的进步正在开发更有效的恐慌症治疗方法。例如，根据美国焦虑和忧郁症协会（ADAA）的数据，2020年，焦虑症是美国最常见的精神疾病，每年影响美国近4000万（18.1%）18岁及以上成年人。我是。根据同一来源，每年，整体焦虑症 (GAD) 影响 680 万成年人（占美国人口的 3.1%），恐慌症 (PD) 影响 600 万成年人（占美国人口的 2.7%）。
然而，也存在着限制市场成长的因素。这个市场的主要挑战之一是与心理健康问题（包括恐慌发作）相关的耻辱。这种耻辱常常阻止个人寻求帮助和治疗。此外，治疗恐慌症的高昂费用和一些地区的报销政策不佳也是市场成长的潜在障碍。
儘管存在这些挑战，市场上仍然存在一些机会。对能够有效控制恐慌发作的个体化、标靶治疗的需求不断增长。此外，虚拟实境技术和人工智慧在恐慌症治疗中的结合有望为市场拓展开闢新的途径。製药主要企业增加对研发活动的投资预计将促进该市场的创新并创造成长机会。
本研究的主要特点
- 该报告对全球恐慌症治疗市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
- 它揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
- 它提供了有关市场驱动因素、抑制因素因素、机会、新产品发布和核准、市场趋势和驱动因素、区域前景、主要企业采取的竞争策略等的重要考察。
- GlaxoSmithKline plc.、F. Hoffmann-La Roche Ltd、Teva Pharmaceutical Industries Ltd.、礼来公司、Bristol-Myers Squibb Company、阿斯特捷利康、辉瑞公司、Johnson & Johnson Services, Inc.、Bausch Health Companies Inc.、H根据公司亮点、产品系列、主要亮点、财务实绩和策略，介绍灵北 A/S 等全球恐慌症治疗市场的主要公司。
- 该报告的见解使行销人员和负责人能够就未来的产品发布、技术升级、市场扩张和行销策略做出资讯的决策。
- 全球恐慌症治疗市场报告针对各种相关人员，如行业投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以从全球恐慌症治疗市场分析中使用的各种策略矩阵中受益，以促进决策。
目录
第一章 研究目的与假设
- 研究目标
- 假设
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 焦虑和恐慌发作的盛行率增加
- 抑制因素
- 药物副作用和安全问题
- 机会
- 远端医疗和电子治疗的使用增加
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 併购场景
第四章全球恐慌症治疗市场－冠状病毒（COVID-19）大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第五章全球恐慌症治疗市场，依药物类别，2018-2030
- 介绍
- 抗忧郁症
- 抗焦虑药
- CGRP拮抗剂
- 其他的
第六章全球恐慌症治疗市场，依给药途径，2018-2030
- 介绍
- 口服
- 静脉
- 肌肉注射
- 舌下
- 其他的
第七章全球恐慌症治疗市场，依配销通路，2018-2030
- 介绍
- 医院药房
- 零售药房
- 线上药房
第八章全球恐慌症治疗市场，按地区，2018-2030
- 介绍
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 东南亚国协
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第9章竞争形势
- GlaxoSmithKline plc.
- Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S
第10章
- 调查方法
- 关于出版商
Global Panic Attack Treatment Market is expected to reach US$ 6.34 Bn by 2030, from US$ 2.14 Bn in 2023, exhibiting a CAGR of 16.8% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 2.14 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 16.80% | 2030 Value Projection: | US$ 6.34 Bn |
Panic attacks are intense episodes of sudden fear or distress that can be debilitating for individuals who experience them. These attacks often come without warning, and can cause physical symptoms such as heart palpitations, shortness of breath, and chest pain. Panic attack treatment focuses on relieving symptoms, reducing the frequency of attacks, and improving overall quality of life.
Market Dynamics:
Global panic attack treatment market is expected to witness significant growth in the near future. The global market growth is driven by several factors including the increasing prevalence of panic disorders worldwide. Rising awareness about mental health, coupled with the growing acceptance and understanding of panic attacks, are also contributing to market growth. Advancements in medical technology and therapeutic interventions have led to the development of more effective treatments for panic attacks. For instance, according to the Anxiety and Depression Association of America (ADAA), in 2020, anxiety disorders are the most common mental illness in the U.S. that affects nearly 40 million adults (18.1%) in the U.S. aged 18 years and older, every year. According to the same source, generalized anxiety disorder (GAD) affects 6.8 million adults, or 3.1% of the U.S. population and panic disorder (PD) affects 6 million adults, or 2.7% of the U.S. population, each year.
However, there are certain factors that may restrain the market growth. One of the key challenges in this market is the stigma associated with mental health issues including panic attacks. This stigma often prevents individuals from seeking help and treatment. Moreover, the high cost of panic attack treatments and a lack of reimbursement policies in some regions are also potential barriers to the market growth.
Despite these challenges, several opportunities exist in the market. There is a growing demand for personalized and targeted therapies that can effectively manage panic attacks. Moreover, the integration of virtual reality technology and artificial intelligence in panic attack treatment is expected to open new avenues for market expansion. Increasing investments in research and development activities by key players in the pharmaceutical industry are likely to boost innovation in this market and create growth opportunities.
Key Features of the Study:
- This report provides in-depth analysis of the global panic attack treatment market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- Key players in the global panic attack treatment market likeGlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., and H. Lundbeck A/S are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies
- Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
- The global panic attack treatment market report caters to various stakeholders, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the industry
- Stakeholders can benefit from various strategy matrices used in analyzing the global panic attack treatment market, which would facilitate ease in decision-making
Detailed Segmentation:
- By Drug Class
- Antidepressants
- Anti-anxiety Drugs
- CGRP Antagonists
- Others
- By Route of Administration
- Oral
- Intravenous
- Intramuscular
- Sublingual
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Top companies in Global Panic Attack Treatment Market:
- GlaxoSmithKline plc.
- F.Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing prevalence of anxiety and panic disorders
- Restraints
- Side effects and safety issues with medications
- Opportunities
- Growing use of telemedicine and e-therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Panic Attack Treatment Market, By Drug Class, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Anti-anxiety Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- CGRP Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Panic Attack Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Panic Attack Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Panic Attack Treatment Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S
- Analyst Views
10. Section
- Research Methodology
- About us
